• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确立针对慢性过敏性肺炎患者的特定疾病健康相关生活质量量表的内容效度。

Establishing content-validity of a disease-specific health-related quality of life instrument for patients with chronic hypersensitivity pneumonitis.

作者信息

Aronson Kerri I, Ali Maha, Reshetynak Evgeniya, Kaner Robert J, Martinez Fernando J, Safford Monika M, Pinheiro Laura C

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine New York, New York, USA.

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

出版信息

J Patient Rep Outcomes. 2021 Jan 14;5(1):9. doi: 10.1186/s41687-020-00282-x.

DOI:10.1186/s41687-020-00282-x
PMID:33443657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7809073/
Abstract

BACKGROUND

Chronic Hypersensitivity Pneumonitis (CHP) is caused by an immune mediated response in the lung tissue after exposure to an inhaled environmental antigenic stimulant. We previously documented the ways in which CHP impacts patients' lives and have now developed a disease-specific instrument, the CHP-HRQOL instrument, to measure health-related quality of life (HRQOL). The objective of this study was to assess content validity for the CHP-HRQOL.

METHODS

Cognitive interviews were conducted among adults with CHP. The instrument was revised and refined between each round of interviews. Feedback was obtained on the instructions, items, response options, and recall period. Items where participants had difficulty with comprehension, wording, or misinterpretation were marked by the interviewer and participant feedback was reviewed to make revisions, add or delete items when appropriate. Readability statistics were calculated using Flesch-Kincaid grade level and reading ease scores.

RESULTS

Ten participants were interviewed over three rounds, with revisions made to the questionnaire in an iterative process. In the initial 39 item instrument, we identified 7 items where two or more participants reported difficulty. Participants preferred a four-week recall period (compared to a two-week recall period) and response options with a 5-point response scale. The final version of the CHP-HRQOL includes 40 items with a median reading level between 6th and 7th grade.

CONCLUSION

The CHP-HRQOL instrument demonstrated high content validity and is ready for psychometric testing in further validation studies.

摘要

背景

慢性过敏性肺炎(CHP)是由肺部组织在接触吸入性环境抗原刺激物后发生的免疫介导反应所引起。我们之前记录了CHP对患者生活的影响方式,并且现已开发出一种针对该疾病的工具——CHP-健康相关生活质量(HRQOL)工具,用于测量健康相关生活质量(HRQOL)。本研究的目的是评估CHP-HRQOL的内容效度。

方法

对患有CHP的成年人进行认知访谈。在每轮访谈之间对该工具进行修订和完善。获取了关于指导语、条目、回答选项和回忆期的反馈。访谈者标记出参与者在理解、措辞或误解方面有困难的条目,并审查参与者的反馈以进行修订,在适当的时候添加或删除条目。使用弗莱什-金凯德年级水平和易读性分数计算可读性统计数据。

结果

在三轮访谈中对10名参与者进行了访谈,并以迭代的方式对问卷进行了修订。在最初的39个条目的工具中,我们确定了7个条目,有两名或更多参与者报告在这些条目上有困难。参与者更喜欢四周的回忆期(与两周的回忆期相比)以及采用5点回答量表的回答选项。CHP-HRQOL的最终版本包括40个条目,阅读水平中位数在6年级和7年级之间。

结论

CHP-HRQOL工具显示出较高的内容效度,并且准备好在进一步的验证研究中进行心理测量测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc4e/7809073/38a4fbc59681/41687_2020_282_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc4e/7809073/38a4fbc59681/41687_2020_282_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc4e/7809073/38a4fbc59681/41687_2020_282_Fig1_HTML.jpg

相似文献

1
Establishing content-validity of a disease-specific health-related quality of life instrument for patients with chronic hypersensitivity pneumonitis.确立针对慢性过敏性肺炎患者的特定疾病健康相关生活质量量表的内容效度。
J Patient Rep Outcomes. 2021 Jan 14;5(1):9. doi: 10.1186/s41687-020-00282-x.
2
The Development and Content Validation of the Sjögren's Related Quality of Life Instrument (SRQoL).干燥综合征相关生活质量量表(SRQoL)的开发与内容效度验证
Rheumatol Ther. 2024 Dec;11(6):1591-1609. doi: 10.1007/s40744-024-00718-6. Epub 2024 Oct 10.
3
A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis.用于慢性过敏性肺炎的系统推导暴露评估工具。
Chest. 2020 Jun;157(6):1506-1512. doi: 10.1016/j.chest.2019.12.018. Epub 2020 Jan 17.
4
The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough.慢性咳嗽日记严重程度表(SCCD):一种评估慢性咳嗽症状体验的新型患者报告结局工具的开发和内容验证。
J Patient Rep Outcomes. 2023 Jul 10;7(1):65. doi: 10.1186/s41687-023-00605-8.
5
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity.一种新型血液系统恶性肿瘤特异性患者报告结局量表(HM-PRO)的开发:内容效度
Front Pharmacol. 2020 Mar 5;11:209. doi: 10.3389/fphar.2020.00209. eCollection 2020.
6
Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.开发一种针对癫痫患者心理治疗干预的患者报告结局测量工具:混合方法研究。
Epilepsy Behav. 2019 Oct;99:106464. doi: 10.1016/j.yebeh.2019.106464. Epub 2019 Aug 14.
7
Development and initial validation of a disease-specific instrument to measure health-related quality of life in hypersensitivity pneumonitis.一种用于测量过敏性肺炎患者健康相关生活质量的疾病特异性工具的开发与初步验证。
ERJ Open Res. 2024 Aug 5;10(4). doi: 10.1183/23120541.00155-2024. eCollection 2024 Jul.
8
Establishing Content Validity of the CLEFT-Q: A New Patient-reported Outcome Instrument for Cleft Lip/Palate.确立唇腭裂患者报告结局量表(CLEFT-Q)的内容效度:一种用于唇腭裂的新型患者报告结局工具
Plast Reconstr Surg Glob Open. 2017 Apr 25;5(4):e1305. doi: 10.1097/GOX.0000000000001305. eCollection 2017 Apr.
9
Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties.肢端肥大症生活质量问卷(ACROQOL):一种针对肢端肥大症患者的新型健康相关生活质量问卷——编制及心理测量特性
Clin Endocrinol (Oxf). 2002 Aug;57(2):251-8. doi: 10.1046/j.1365-2265.2002.01597.x.
10
Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.肺动脉高压-症状与影响(PAH-SYMPACT®)问卷的开发:一种新的肺动脉高压患者报告结局工具。
Respir Res. 2016 Jun 14;17(1):72. doi: 10.1186/s12931-016-0388-6.

引用本文的文献

1
Development and initial validation of a disease-specific instrument to measure health-related quality of life in hypersensitivity pneumonitis.一种用于测量过敏性肺炎患者健康相关生活质量的疾病特异性工具的开发与初步验证。
ERJ Open Res. 2024 Aug 5;10(4). doi: 10.1183/23120541.00155-2024. eCollection 2024 Jul.
2
Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort.疲劳严重程度量表在真实世界间质性肺疾病队列中的有效性和可靠性。
Am J Respir Crit Care Med. 2023 Jul 15;208(2):188-195. doi: 10.1164/rccm.202208-1504OC.
3
Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs).

本文引用的文献

1
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.成人过敏性肺炎的诊断。美国胸科学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST.
2
A simple method to assess and report thematic saturation in qualitative research.一种评估和报告定性研究主题饱和度的简单方法。
PLoS One. 2020 May 5;15(5):e0232076. doi: 10.1371/journal.pone.0232076. eCollection 2020.
3
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
一天与七天回忆间隔对患者报告结局测量(PROMs)效果的系统评价。
Patient. 2023 May;16(3):201-221. doi: 10.1007/s40271-022-00611-w. Epub 2023 Feb 14.
4
Health Related Quality of Life in Interstitial Lung Disease: Can We Use the Same Concepts Around the World?间质性肺疾病的健康相关生活质量:我们能在全球使用相同的概念吗?
Front Med (Lausanne). 2021 Oct 6;8:745908. doi: 10.3389/fmed.2021.745908. eCollection 2021.
尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
4
Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL).1个月回忆期子宫肌瘤症状与健康相关生活质量问卷(UFS-QOL)的心理测量学验证
J Patient Rep Outcomes. 2019 Aug 23;3(1):57. doi: 10.1186/s41687-019-0146-x.
5
Hypersensitivity Pneumonitis: Current Concepts of Pathogenesis and Potential Targets for Treatment.过敏性肺炎:发病机制的当前概念及潜在治疗靶点
Am J Respir Crit Care Med. 2019 Aug 1;200(3):301-308. doi: 10.1164/rccm.201903-0541PP.
6
Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort Study.大型超敏性肺炎队列中皮质类固醇治疗和避免接触抗原的效果:一项单中心队列研究
J Clin Med. 2018 Dec 21;8(1):14. doi: 10.3390/jcm8010014.
7
Hypersensitivity pneumonitis: Antigen diversity and disease implications.过敏性肺炎:抗原多样性与疾病意义。
Pulmonology. 2019 Mar-Apr;25(2):97-108. doi: 10.1016/j.pulmoe.2018.07.003. Epub 2018 Aug 17.
8
Saturation in qualitative research: exploring its conceptualization and operationalization.定性研究中的饱和度:探索其概念化与操作化
Qual Quant. 2018;52(4):1893-1907. doi: 10.1007/s11135-017-0574-8. Epub 2017 Sep 14.
9
Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.间质性肺疾病生活质量评估:疾病特异性 K-BILD 与通用 EQ-5D-5L 的比较。
Respir Res. 2018 May 25;19(1):101. doi: 10.1186/s12931-018-0808-x.
10
Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-based Cohort Analysis.美国保险人群中过敏性肺炎的流行病学:基于理赔的队列分析。
Ann Am Thorac Soc. 2018 Apr;15(4):460-469. doi: 10.1513/AnnalsATS.201704-288OC.